UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000060557 |
|---|---|
| Receipt number | R000069272 |
| Scientific Title | Sleep Status Verification Study Through Continuous Intake of Test Food: a randomized, double blind, placebo-controlled study |
| Date of disclosure of the study information | 2026/02/03 |
| Last modified on | 2026/02/03 10:38:59 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Sleep Status Verification Study Through Continuous Intake of Test Food
Acronym
Sleep Status study
Scientific Title
Sleep Status Verification Study Through Continuous Intake of Test Food: a randomized, double blind, placebo-controlled study
Scientific Title:Acronym
Sleep Status Verification Study Through Continuous Intake of Test Food
Region
| Japan |
Condition
Condition
Healthy adult
Classification by specialty
| Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To verify the effects on sleep when the test articles is consumed continuously for 8 weeks
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
OSA sleep inventory MA version, VAS, Instrumental measurement
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
3
Purpose of intervention
Treatment
Type of intervention
| Food |
Interventions/Control_1
Continuous intake of one packet of the test article A daily before bedtime for 8 weeks.
Interventions/Control_2
Continuous intake of one packet of the test article B daily before bedtime for 8 weeks.
Interventions/Control_3
Continuous intake of one packet of the placebo daily before bedtime for 8 weeks.
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 59 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
1. Subjects dissatisfied with or concerned about their sleep quality
2. Subjects experiencing fatigue in daily life
3. Subjects with a BMI between 19 and 26
4. Subjects who use a smartphone and can download and use an app.
Key exclusion criteria
1. Subjects satisfied with their sleep quality, somewhat satisfied, or neither satisfied nor dissatisfied
2. Pregnant women, breastfeeding individuals, or those who may be pregnant
3. Subjects working night shifts or rotating day-night shifts
4. Subjects currently receiving medical treatment or taking prescription medication
5. Subjects diagnosed by a physician with sleep disorders such as insomnia
6. Subjects taking sleeping pills or sleep supplements (e.g., melatonin)
7. Subjects undergoing hormone replacement therapy
8. Subjects who participated in another human trial within the past month or are currently participating in one
9. Subjects whose trial date falls within 2 weeks of their most recent vaccination
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Takeshi |
| Middle name | |
| Last name | Kaneko |
Organization
Japan Clinical Trial Association
Division name
N.A.
Zip code
1600022
Address
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
TEL
0364574666
info@yakujihou.org
Public contact
Name of contact person
| 1st name | Takeshi |
| Middle name | |
| Last name | Kaneko |
Organization
Japan Clinical Trial Association
Division name
N.A.
Zip code
1600022
Address
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
TEL
0364574666
Homepage URL
info@yakujihou.org
Sponsor or person
Institute
Japan Clinical Trial Association
Institute
Department
Personal name
Funding Source
Organization
UNITEC FOODS CO.,LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Institutional Review Board of Pharmaceutical Law Wisdoms
Address
5F, 4-3-17 Shinjuku, Shinjukuku, Tokyo
Tel
0364574911
master@yakujihou.net
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 02 | Month | 03 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2026 | Year | 01 | Month | 13 | Day |
Date of IRB
| 2026 | Year | 01 | Month | 15 | Day |
Anticipated trial start date
| 2026 | Year | 02 | Month | 03 | Day |
Last follow-up date
| 2026 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2026 | Year | 02 | Month | 03 | Day |
Last modified on
| 2026 | Year | 02 | Month | 03 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069272
